KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,455,289 | +12.4% | 3,077,449 | -8.9% | 2.00% | -1.4% |
| Q2 2023 | $47,564,549 | +59.3% | 3,378,164 | +21.7% | 2.03% | +162.8% |
| Q1 2023 | $29,865,843 | +27.0% | 2,775,636 | +76.8% | 0.77% | -24.5% |
| Q4 2022 | $23,511,155 | +26.6% | 1,569,503 | +8.5% | 1.02% | +9.6% |
| Q3 2022 | $18,568,000 | +266.0% | 1,446,107 | +176.2% | 0.94% | +251.5% |
| Q2 2022 | $5,073,000 | +189.9% | 523,528 | +240.8% | 0.27% | +442.9% |
| Q3 2021 | $1,750,000 | – | 153,618 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
| Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
| HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
| TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
| Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
| AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
| RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
| Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
| Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
| Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |